Related Experiment Videos
The National Cancer Data Base. Report on colon cancer
J M Jessup1, L S McGinnis, G D Steele
1Commission on Cancer, American College of Surgeons, Chicago, Illinois 60611, USA.
Cancer
|August 15, 1996
Summary
Trends in colon cancer show elderly patients present with earlier stages. Adjuvant chemotherapy improves survival for Stage III patients, highlighting its growing importance.
Area of Science:
- Oncology
- Cancer Epidemiology
- Clinical Research
Background:
- The Commission on Cancer's National Cancer Data Base (NCDB) tracks cancer stage, treatment, and survival trends.
- This analysis focuses on the most current (1993) data for colon cancer patients.
Purpose of the Study:
- To describe time trends in stage of disease, treatment patterns, and survival for colon cancer patients using NCDB data.
- To identify demographic and clinical factors influencing colon cancer presentation and outcomes.
Main Methods:
- Utilized NCDB data from 1985-1993, encompassing over 3.7 million cancer cases.
- Specifically analyzed 36,937 colon cancer cases from 1988 and 44,812 from 1993.
Main Results:
- Elderly patients (>80 years) presented with earlier stage disease compared to younger individuals.
- African-Americans showed a slightly higher incidence of Stage IV disease.
- A trend of proximal migration of colon cancer primaries was observed (right colon: 54.7% in 1993 vs. 50.9% in 1988).
- Adjuvant chemotherapy in Stage III colon cancer patients correlated with a 5% improvement in 5-year relative survival.
Conclusions:
- NCDB data effectively report U.S. cancer treatment administration and outcomes.
- Cancer grade appears to have a significant biologic role.
- While outcomes are similar across ethnic groups, disparities in medical care access may persist for African-Americans.
- The benefit of adjuvant therapy for Stage III colon cancer is increasingly recognized.